SCHEMBL574275

SCHEMBL574275

CCCCN(CCCC)c1cc(C(=O)NCCO)cc(S(N)(=O)=O)c1Oc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 7/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ USP2 O75604 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ LMNA P02545 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ HIF1A Q16665 2/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ TSHR P16473 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ SLC12A2 P55011 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ AQP1 P29972 1/20 0.51
▸ PTGS2 P35354 10/20 0.46
▸ CA12 O43570 6/20 0.40
▸ CA1 P00915 6/20 0.40
▸ CA3 P07451 6/20 0.40
▸ CA6 P23280 6/20 0.40
▸ CA7 P43166 6/20 0.40
▸ CA13 Q8N1Q1 6/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741903 0.94 CA2 (0.56) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741900 0.94 CA2 (0.58) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741897 0.94 CA2 (0.55) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL230463 0.93 CA2 (0.52) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741899 0.93 CA2 (0.54) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741911 0.92 CA2 (0.53) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741901 0.92 CA2 (0.54) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741904 0.89 CA2 (0.52) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL2741896 0.89 KDM4E (0.57) CA2KDM4EUSP2ALDH1A1LMNA
SCHEMBL18993673 0.87 CA2 (0.49) CA2KDM4EUSP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback